Literature DB >> 14748744

Production of a new model of slowly progressive Heymann nephritis.

Arpad Z Barabas1, Chad D Cole, Arpad D Barabas, Rene Lafreniere.   

Abstract

A slowly progressive autoimmune kidney disease was induced in Sprague Dawley rats by subcutaneous injection of a chemically modified kidney antigen (rKF3), incorporated into Alum and Distemper complex vaccine, followed by subcutaneous injections of an aqueous preparation of the same antigen. Pathogenic autoantibodies developed, which reacted with fixed glomerular nephritogenic antigen. Subsequently, immunopathological events lead to chronic progressive immune complex glomerulonephritis and proteinuria. The slowly developing disease was morphologically and functionally similar to Heymann nephritis (HN). The damage observed in the kidneys of experimental animals at 8 weeks and at the end of the experiment was examined by direct fluorescent antibody test, histology and electron microscopy. The changes were similar to the typical lesions found in HN rat kidneys, but less severe. Animals became proteinuric from 17 weeks onward (instead of the usual 4-8 weeks). By the end of the experiment, at 8 months, 100% of the rats were proteinuric. This new experimental model of autoimmune kidney disease, which is not complicated by intraperitoneal deposition and retention of Freund's complete adjuvant and renal tubular antigens, allowed us to investigate the pathogenesis of the disease processes from a different aspect, and promises to be a useful and improved model for the investigation of future treatment options.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14748744      PMCID: PMC2517567          DOI: 10.1111/j.0959-9673.2003.00358.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  56 in total

1.  DEPOSITION OF AUTOLOGOUS GAMMA GLOBULIN IN KIDNEYS OF RATS WITH NEPHROTIC RENAL DISEASE OF VARIOUS ETIOLOGIES.

Authors:  R OKUDA; M H KAPLAN; F E CUPPAGE; W HEYMANN
Journal:  J Lab Clin Med       Date:  1965-08

2.  Experimental glomerulonephritis.

Authors:  D J Salant; A V Cybulsky
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  Formation of immune deposits and disease.

Authors:  G Andres; J R Brentjens; P R Caldwell; G Camussi; S Matsuo
Journal:  Lab Invest       Date:  1986-11       Impact factor: 5.662

4.  Induction of an autologous immune-complex glomerulonephritis in the rat by intravenous injection of heterologous anti-rat kidney tubular antibody. I. Production of chronic progressive immune-complex glomerulonephritis.

Authors:  A Z Barabas; R Lannigan
Journal:  Br J Exp Pathol       Date:  1974-02

5.  Auto-immune nephritis in rats.

Authors:  A Z Barabas; R Lannigan
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

6.  Effect of ciclosporin on active Heymann nephritis.

Authors:  D C Cattran
Journal:  Nephron       Date:  1988       Impact factor: 2.847

7.  Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.

Authors:  Y Fujigaki; S Batsford; F Yamashita; K Yonemura; A Hishida; H Kawachi; F Shimizu; A Vogt
Journal:  Virchows Arch       Date:  2001-02       Impact factor: 4.064

8.  Suppression of experimental membranous glomerulonephritis in rats by an anti-MHC class II antibody.

Authors:  Y Hasegawa; H Kaneoka; T Tanaka; S Ogahara; T Matsumae; R Noda; K Yoshitake; T Murata; S Naito
Journal:  Nephron       Date:  2001-07       Impact factor: 2.847

9.  Factors influencing susceptibility of LEW rats to Heymann nephritis.

Authors:  B Noble; J B Van Liew; G A Andres; J R Brentjens
Journal:  Clin Immunol Immunopathol       Date:  1984-02

10.  Effect of reimmunization with Fx1A late in the course of Heymann nephritis.

Authors:  B Noble; J B Van Liew; J R Brentjens; G A Andres
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

View more
  8 in total

1.  Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes.

Authors:  Arpad Z Barabas; Chad D Cole; Maria Sensen; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2011-11-22       Impact factor: 1.925

Review 2.  Regaining tolerance to a self-antigen by the modified vaccination technique.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere; Donald Mackay Weir
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

3.  Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

Review 4.  Antibody-initiated beneficial and harmful immune responses.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

5.  Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Jord M Cowan; Chang Soon Yoon; David M Waisman; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

6.  Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Richard Milton Graeff; Rene Lafreniere; Donald Mackay Weir
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Production of Heymann nephritis by a chemically modified renal antigen.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

8.  Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Biologics       Date:  2007-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.